[HTML][HTML] Identification of compounds with glucocorticoid sparing effects on suppression of chemokine and cytokine production by rheumatoid arthritis fibroblast-like …
In recent years target based drug discovery has expanded our therapeutic armamentarium
in the treatment of inflammatory and autoimmune diseases. Despite these advances and …
in the treatment of inflammatory and autoimmune diseases. Despite these advances and …
[HTML][HTML] Identification of Compounds With Glucocorticoid Sparing Effects on Suppression of Chemokine and Cytokine Production by Rheumatoid Arthritis Fibroblast …
T Hosoya, NM Shukla, Y Fujita, S Yao… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
In recent years target based drug discovery has expanded our therapeutic armamentarium
in the treatment of inflammatory and autoimmune diseases. Despite these advances and …
in the treatment of inflammatory and autoimmune diseases. Despite these advances and …
Identification of Compounds With Glucocorticoid Sparing Effects on Suppression of Chemokine and Cytokine Production by Rheumatoid Arthritis Fibroblast-Like …
T Hosoya, NM Shukla, Y Fujita, S Yao… - Frontiers in …, 2020 - hero.epa.gov
In recent years target based drug discovery has expanded our therapeutic armamentarium
in the treatment of inflammatory and autoimmune diseases. Despite these advances and …
in the treatment of inflammatory and autoimmune diseases. Despite these advances and …
Identification of Compounds With Glucocorticoid Sparing Effects on Suppression of Chemokine and Cytokine Production by Rheumatoid Arthritis Fibroblast-Like …
T Hosoya, NM Shukla, Y Fujita, S Yao… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
In recent years target based drug discovery has expanded our therapeutic armamentarium
in the treatment of inflammatory and autoimmune diseases. Despite these advances and …
in the treatment of inflammatory and autoimmune diseases. Despite these advances and …
Identification of Compounds With Glucocorticoid Sparing Effects on Suppression of Chemokine and Cytokine Production by Rheumatoid Arthritis Fibroblast-Like …
T Hosoya, N Shukla, Y Fujita, S Yao, F Lao… - Frontiers in …, 2020 - europepmc.org
In recent years target based drug discovery has expanded our therapeutic armamentarium
in the treatment of inflammatory and autoimmune diseases. Despite these advances and …
in the treatment of inflammatory and autoimmune diseases. Despite these advances and …
Identification of Compounds With Glucocorticoid Sparing Effects on Suppression of Chemokine and Cytokine Production by Rheumatoid Arthritis Fibroblast-Like …
T Hosoya, NM Shukla, Y Fujita, S Yao, FS Lao… - Frontiers in …, 2020 - cir.nii.ac.jp
抄録< jats: p> In recent years target based drug discovery has expanded our therapeutic
armamentarium in the treatment of inflammatory and autoimmune diseases. Despite these …
armamentarium in the treatment of inflammatory and autoimmune diseases. Despite these …
Identification of Compounds With Glucocorticoid Sparing Effects on Suppression of Chemokine and Cytokine Production by Rheumatoid Arthritis Fibroblast-Like …
T Hosoya, NM Shukla, Y Fujita, S Yao… - Frontiers in …, 2020 - europepmc.org
In recent years target based drug discovery has expanded our therapeutic armamentarium
in the treatment of inflammatory and autoimmune diseases. Despite these advances and …
in the treatment of inflammatory and autoimmune diseases. Despite these advances and …